Maqola

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Kornelia KotsevaEuropean Society of Cardiology, Sophia Antipolis, FranceGuy De BackerDepartment of Public Health and Primary Care, Ghent University, BelgiumDirk De BacquerEuropean Society of Cardiology, Sophia Antipolis, FranceLars RydénEuropean Society of Cardiology, Sophia Antipolis, FranceArno W. HoesJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The NetherlandsDiederick E. GrobbeeJulius Global Health, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The NetherlandsAldo P. MaggioniEuropean Society of Cardiology, Sophia Antipolis, FrancePedro Marques‐VidalDepartment of Medicine, Internal Medicine, Lausanne University Hospital, SwitzerlandCatriona JenningsNational Heart and Lung Institute, Imperial College London, UKAna AbreuHospital de Santa MartaCarlos AguíarHospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Lisbon, PortugalJolita BadarienėCentre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, LithuaniaJan BruthansEuropean Society of Cardiology, Sophia Antipolis, FranceAlmudena Castro CondeCardiac Rehabilitation Unit, Cardiology Department, Hospital Universitario La Paz, Madrid, SpainRenata CífkováCentre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech RepublicJim CrowleyDepartment of Cardiology, Galway University Hospital and Croí, the West of Ireland Cardiac and Stroke Foundation, Croí Heart and Stroke Centre, Galway, IrelandKairat DavletovSchool of Public Health, Public Health Research Centre, Kazakh National Medical University, Almaty, KazakhstanJaap W. DeckersErasmus University RotterdamDelphine De SmedtEuropean Society of Cardiology, Sophia Antipolis, FranceJohan De SutterDepartment of Internal Medicine and Paediatrics, Ghent University, BelgiumMirza DilićMedical Faculty, University of Sarajevo, Bosnia and HerzegovinaMarina DolzhenkoSupyk National Medical Academy of Postgraduate Education, Kiev, UkraineVilnis DzērveEuropean Society of Cardiology, Sophia Antipolis, FranceAndrejs ĒrglisEuropean Society of Cardiology, Sophia Antipolis, FranceZlatko FrasEuropean Society of Cardiology, Sophia Antipolis, FranceDan GaițăEuropean Society of Cardiology, Sophia Antipolis, FranceNina GotchevaNational Heart Hospital, Dept Cardiology, Sofia, BulgariaPeter U. HeuschmannComprehensive Heart Failure Centre, University and University Hospital Würzburg, GermanyHosam Hasan‐AliAssiut University Heart Hospital, Cardiovascular Medicine Department, EgyptPiotr JankowskiDepartment of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, PolandNebojša LalićDepartment for Metabolic Disorder, Intensive Treatment and Cell Therapy in Diabetes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Belgrade, SerbiaSeppo LehtoEuropean Society of Cardiology, Sophia Antipolis, FranceDragan LovićClinic for Internal Disease Intermedic, Cardiology Department, Hypertension Centre, Nis, SerbiaS. MancasUniversitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, RomaniaLinda MellbinDepartment of Medicine Solna, Karolinska Institutet, Stockholm, SwedenDavor MiličićEuropean Society of CardiologyErkin М МirrakhimovEuropean Society of Cardiology, Sophia Antipolis, FranceР. Г. ОгановNational Research Centre for Preventive Medicine, Directorate, Moscow, RussiaNana PogosovaFederal State Budget Organization, National Medical Research Centre of Cardiology of the Ministry of Healthcare of the Russian Federation, Moscow, RussiaŽeljko ReinerEuropean Society of CardiologyStefan StörkComprehensive Heart Failure Centre, University and University Hospital Würzburg, GermanyLâle TokgözoğluEuropean Society of Cardiology, Sophia Antipolis, FranceCostas TsioufisFirst Department of Cardiology, Medical School, National and Kapodistrian University of Athens, GreeceDuško VulićCentre for Medical Research, School of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and HerzegovinaDavid WoodNational Heart and Lung Institute, Imperial College London, UKon behalf of the EUROASPIRE Investigators*

2019en

Ochiq kirishYashil

ABI

Annotatsiya

AIMS: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. DESIGN: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. METHODS: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. RESULTS: ), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. CONCLUSION: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1177/2047487318825350

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba